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Synthesis and functionalization of virus-mimicking cationic block
copolymers with pathogen-associated carbohydrates as potential vaccine
adjuvants
Abstract
We report the synthesis of a family of amphiphilic pentablock polymers with different cationic blocks and
with controlled architectures as potential vaccine carriers for subunit vaccines. The temperature and pH-
dependent micellization and gelation of these pentablock copolymers can provide a depot for sustained
protein and gene delivery. The amphiphilic central triblock promotes cellular endocytosis, good gene delivery
and has been used effectively as a vaccine adjuvant. The pentablock copolymer outer blocks condense DNA
spontaneously as a result of electrostatic interactions for sustained combinational therapy. This family of
polymers with different cationic groups was evaluated based on DNA complexation-ability and cytotoxicity to
select promising candidates as DNA-based subunit vaccine adjuvants. Modification of other polymer systems
with carbohydrates like mannose has been shown to enhance immunogenicity by activating pattern
recognition receptors on antigen presenting cells and increasing uptake in these cells. Here, we report the
synthesis of a virus-mimicking pentablock copolymer vaccine platform by successful functionalization of
these polymers with mannose through an azide–alkyne Huisgen cycloaddition. The synthesis of a mannoside
with the alkyne linker was achieved by a recently reported bismuth(V)-mediated activation of a thioglycoside
that proved to leave the alkyne intact. The carbohydrate modification was shown not to interfere with the
ability of these virus-mimicking block copolymers to complex DNA, thereby making this family of modified
materials promising candidates for DNA-based vaccine delivery.
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Synthesis and functionalization of virus-mimicking
cationic block copolymers with pathogen-
associated carbohydrates as potential vaccine
adjuvants†
J. R. Adams,‡a M. Goswami,‡b N. L. B. Pohlac and S. K. Mallapragada*a
We report the synthesis of a family of amphiphilic pentablock polymers with diﬀerent cationic blocks and
with controlled architectures as potential vaccine carriers for subunit vaccines. The temperature and pH-
dependent micellization and gelation of these pentablock copolymers can provide a depot for sustained
protein and gene delivery. The amphiphilic central triblock promotes cellular endocytosis, good gene
delivery and has been used eﬀectively as a vaccine adjuvant. The pentablock copolymer outer blocks
condense DNA spontaneously as a result of electrostatic interactions for sustained combinational
therapy. This family of polymers with diﬀerent cationic groups was evaluated based on DNA
complexation-ability and cytotoxicity to select promising candidates as DNA-based subunit vaccine
adjuvants. Modiﬁcation of other polymer systems with carbohydrates like mannose has been shown to
enhance immunogenicity by activating pattern recognition receptors on antigen presenting cells and
increasing uptake in these cells. Here, we report the synthesis of a virus-mimicking pentablock
copolymer vaccine platform by successful functionalization of these polymers with mannose through an
azide–alkyne Huisgen cycloaddition. The synthesis of a mannoside with the alkyne linker was achieved
by a recently reported bismuth(V)-mediated activation of a thioglycoside that proved to leave the alkyne
intact. The carbohydrate modiﬁcation was shown not to interfere with the ability of these virus-
mimicking block copolymers to complex DNA, thereby making this family of modiﬁed materials
promising candidates for DNA-based vaccine delivery.
Introduction
Block copolymers based on Pluronics have been used in a
variety of applications, including sustained drug delivery,
therapeutic cellular transfection and as novel vaccine adju-
vants.1–3 Pluronic F127 is an FDA-approved surfactant that
exhibits temperature and pH-dependent gelation properties
that make it an ideal carrier for hydrophobic drugs such as
paclitaxel, aspirin and antibiotics.4–8 Pluronic F127 has a central
hydrophobic chain of polyoxypropylene and two outer hydro-
philic chains of polyoxyethylene.9 The hydrophobic interactions
between the collapsed polyoxypropylene blocks result in the
formation of micelles.10 There are several advantageous prop-
erties of Pluronic that make it suitable for antigen delivery
including cellular uptake through endocytosis and high gene
expression.3,4,9,11 There is also evidence that hydrophobic
portions of synthetic polymers can initiate immune
responses.12,13
Our research group has previously synthesized a family of
cationic pentablock copolymers based on Pluronics for drug
delivery.14 The pentablock copolymers, which are synthesized
using Pluronic macroinitiators and atom transfer radical poly-
merization (ATRP) of the outer cationic blocks, oﬀer several
critical advantages for DNA-based vaccine delivery. The amine
groups on the pentablock copolymer outerblocks can form
nanoscale complexes with DNA spontaneously as a result of
electrostatic interactions.15 Detailed studies with one of these
pentablock copolymers with poly(2-diethylaminoethyl methac-
rylate) (PDEAEM) cationic blocks, have shown that the polymer
micelles aggregate to form physical gels at high polymer
concentrations. This enables the pentablock copolymers to
serve as a unique multi-purpose platform to condense DNA,
enable sustained gene delivery from the pentablock copolymer
gels, and also provide combinational therapy of gene and drug
co-delivery from the same platform.10,16,17 However, the eﬀect of
diﬀerent cationic blocks on DNA complexation ability as well as
cytotoxicity of the copolymers has not been investigated. Herein
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we synthesize four pentablock copolymers based on Pluronic
with end blocks of PDEAEM, poly(2-dimethylaminoethyl
methacrylate), poly(2-diisopropylaminoethyl methacrylate) or
poly-(tert-butylaminoethyl methacrylate) abbreviated PDMAEM,
PDiPAEM and PtBAEM, respectively. These polymers with
diﬀerent cationic groups were then evaluated for suitability in a
DNA-based vaccine formulation through DNA condensation
and cellular cytotoxicity studies to select lead candidates.
To establish protective immunity, vaccines can enhance an
innate immune response by activating antigen presenting cells
(APCs).18 Dendritic cells are a critical type of APCs that are
present in all body tissues.19 Immature dendritic cells can
activate directly from pattern recognition receptors (PRRs) that
recognize pathogen-associated molecular patterns (PAMPs).19
Carbohydrates; such as mannose, have been shown to act as
PAMPs which can target carbohydrate-recognition receptors,
specically C-type lectin receptors abundantly expressed on
dendritic cells.20–22 Ligation of C-type lectin receptors with
mannose structures displayed by pathogen glycoproteins leads
to internalization of pathogens for antigen loading of major
histocompatibility molecules.21,23 Therefore, nano-scale adju-
vants with attached carbohydrates can act as virus-mimicking
particles such as mannose containing HIV-1 and measles virus,
and increase dendritic cell transfection eﬃciencies through
receptor mediated endocytosis and presentation of processed
antigen to T cells.22 In this work, we demonstrate the successful
functionalization of this family of pentablock copolymer
vaccine candidates with D-mannose through an azide–alkyne
Huisgen click reaction.24,25 Furthermore, gel electrophoresis
studies show that the mannose functionalization of the copol-
ymers does not aﬀect the ability of the polymers to complex with
DNA. A diagram showing the interaction of mannose func-
tionalized pentablock copolymer DNA polyplexes interacting
with PRRs on a dendritic cell can be found in Scheme 1.
Experimental section
Reagents
2-N,N-(Diisopropylamino)ethyl methacrylate (DiPAEM), tert-
butylaminoethyl methacrylate (tBAEM) and inhibitor removal
columns were purchased from Scientic Polymer Products Inc.,
Ontario, NY. N,N-(Dimethylamino)ethyl methacrylate (DMAEM),
N,N-(diethylamino)ethyl methacrylate (DEAEM), Pluronic F127
(Mn ¼ 12 600, 70% PEO), and D-mannose were purchased from
Sigma-Aldrich, St. Louis, MO. Triphenyl bismuth was purchased
from Strem Chemicals, Newburyport, MA. Slide-A-Lyzer® G2
Dialysis Cassettes (10 kDa Mw cut oﬀ) were purchased from
Thermo Scientic, Rockford, IL. All other chemicals were
purchased fromFisher Scientic, Pittsburgh, PA. The synthesis of
N-propyl-pyridynyl methanimine (NPPM) from 1-propylamine
and 2-pyridinecarbaldehyde has been previously reported.14
General experimental
Air- and moisture-sensitive reactions were carried out in oven-
dried or ame-dried glassware, septum-capped under atmo-
spheric pressure of argon. Commercially available compounds
were used without further purication unless otherwise stated.
The exact reaction conditions are given in the respective
procedures. Air- and moisture-sensitive liquids and solutions
were transferred via syringe or stainless steel cannula. All
saccharides and the Bi(V) reagent were pre-dried by azeotropic
removal of water using anhydrous toluene. Flash silica gel
column chromatography was performed employing Silica Gel
60 Sorbent (40–63 mm, 230–400 mesh). Thin-layer chromatog-
raphy (analytical) was performed using glass plates pre-coated
to a depth of 0.25 mm detected under UV light and by spraying
the plates with a 0.02 M solution of resorcinol in 20% ethanolic
H2SO4 solution followed by heating.
Instrumentation
Proton (1H) NMR, carbon (13C) NMR, 1H-13C HSQC were recor-
ded on a Bruker Avance III 600 MHz (or Varian VXR 300 MHz),
125 MHz instrument respectively using the residual signals
from chloroform (CDCl3), 7.26 ppm and 77.0 ppm as internal
references for 1H and 13C chemical shis (d) respectively. Elec-
trospray ionization high-resolution mass spectrometry (ESI-
HRMS) was carried out on an Agilent 6540 QTOF. Optical
rotations were measured at 20 C using an automatic polarim-
eter AP300. Melting points were recorded in capillary tubes on a
Digimelt SRS. IR spectroscopy was recorded by putting a thin
lm of the analyte on a salt plate on a Perkin-Elmer instrument.
Preparation of Pluronic macrointiator
Pluronic F127 (40.0 g, 3.20 mmol) was dissolved in tetrahydro-
furan in a round-bottom ask over an ice bath. Triethylamine
(20.0 mL, 143 mol) and 2-bromoisobutyryl bromide (3.00 mL,
24.2 mmol) were then added to the round-bottom ask. The
reaction proceeded for 20 h up until the removal of solvent
under reduced pressure and the precipitation of Pluronic
macrointiator with n-heptane inside of a dry ice bath. The
characterization of Pluronic macrointiator by 1H NMR has been
previously described.14
Synthesis & characterization of the pentablock copolymer
family
The PDEAEM, PDMAEM, PtBAEM and PDiPAEM pentablock
copolymers were synthesized via ATRP with the Pluronic mac-
rointiator. The macrointiator (10.0 g, 0.780 mmol) and copper(I)
bromide (0.240 g, 1.67 mmol) were dissolved in toluene inside
Scheme 1 Illustration of mannose functionalized pentablock copol-
ymer condensing DNA and interacting with pattern recognition
receptors (PRRs) on an antigen presenting cell.
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of an argon ushed single neck round bottom ask. The NPPM
ligand (0.500 mL, 3.40 mmol) and respective monomer (2.50
mmol) were added and the reaction ask was degassed via three
freeze–pump–thaw cycles. A small volume of inert gas was
added and the reaction was stirred at 70 C in an oil bath. Aer
20 h the reacted product was passed through a basic alumina
column with a 1 : 1 dichloromethane–toluene solution. The
eluate was concentrated under reduced pressure. The product
was then precipitated using chilled n-heptane and le to dry in a
vacuum oven maintained at 25 inches Hg vacuum (125 Torr).
DNA gel electrophoresis
To investigate the DNA condensation ability of polymers, the
self-assembled pentablock copolymers were mixed with DNA in
Hank's Balanced Salt Solution (HBSS) at diﬀerent N/P ratios to
form polyplexes. The polyplexes were briey vortexed and
incubated at room temperature for 20 min to ensure complex-
ation. The samples were prepared in TriTrack sample buﬀer
and a 15 mL volume was loaded onto a 0.70% agarose gel con-
taining 0.1 mg mL1 ethidium bromide. These polyplexes were
run on an agarose gel with a constant of 1 mg of DNA per lane.
The gel was run in Tris–acetate EDTA buﬀer at 75 V for
approximately 2 h. All uorescent images were captured on a
UVP BioDoc-It® Imaging System with a 1.3 megapixel camera.
Cytotoxicity studies
The cytotoxicity of the diﬀerent pentablock copolymers was
tested using an in vitro CellTiter 96® Non-Radioactive Cell
Proliferation Assay (Promega, Wisconsin, United States). EL4
C57BL/6 mice lymphoma cells were seeded on a 96 well plate
with a density of 10 000 cells per well and incubated at 37 C
for 24 h in a humidied, 5% CO2 atmosphere. Pentablock
copolymers dissolved in HBSS Buﬀer were added at concen-
trations calculated from an NP ratio of 20 for 0.2 mg and 0.6 mg
of DNA and incubated with the cells at 37 C for an additional
24 h. A 15 mL volume of the Promega tetrazolium salt reagent
was added to each well, the 96 well plate was incubated for an
additional 4 h and then a 100 mL volume of the Promega
solubilization solution was added to each well. Aer an
additional 1 h of incubation, absorbance values were recor-
ded with a microplate reader at 570 nm wavelength and a
subtracted 690 nm reference wavelength. Corrected absor-
bance values were found by subtracting an average absor-
bance value of the 100% lysed positive control cells. The cell
viability numbers were calculated by dividing the corrected
absorbance value by an average of the non-treated negative
control cells.
Functionalization of pentablock copolymer with azide linker
Pentablock copolymer (5.40 g) and sodium azide (0.243 g, 3.60
mmol) were dissolved in N,N-dimethylformamide and reacted
at 50 C for 24 h. The reacted product was precipitated in chilled
n-heptane, collected using a Bu¨chner funnel and le in a
vacuum oven to dry.
Synthesis of alkynyl mannose analogue
n-Propyl-2,3,4,6-tetra-O-acetyl-1-thio-a-D-mannopyranoside
(2). A 0.500 M solution of peracetylated donor 1 (ref. 26) (2.00 g,
5.77 mmol, 1.0 equiv.) and propanethiol (PrSH, 0.571 g, 7.50
mmol, 1.3 equiv.) were stirred for 0.5 h in anhydrous
dichloromethane at 0 C. Then, boron triuoride dietherate
(BF3$OEt2, 1.23 g, 8.65 mmol, 1.5 equiv.) was added drop wise at
0 C to the reaction mixture and then the reaction was le to stir
at ambient temperature for 16 h. The reaction was quenched
with excess triethylamine, diluted with CH2Cl2, ltered, and
washed sequentially with 2 M aqueous HCl, saturated aqueous
NaHCO3, and water. The organic layer was dried over MgSO4
and concentrated under reduced pressure at 40 C; the resulting
residue was puried by silica gel column chromatography with
hexane:ethyl acetate (4 : 1) to yield 2 as a white solid (1.95 g, 4.78
mmol, 83%); Rf 0.48 (hexanes–ethyl acetate 3 : 1); [a]
D +73.3 cm3
g1 dm1 (c 0.012 g cm3, CHCl3;
1H NMR) (600 MHz, [D1]
CDCl3, 25 C, TMS) d ¼ 5.32 (dd, J ¼ 3.1, 1.6, 1H; H-3), 5.28 (m,
1H; H-2), 5.25 (d, J¼ 3.1, 1H; H-1a), 5.23 (m, 1H; H-4), 4.37 (ddd,
J ¼ 9.3, 5.4, 2.3, 1H; H-5), 4.28 (dd, J ¼ 12.2, 5.5, 1H; H-6a), 4.07
(dd, J ¼ 12.3, 2.4, 1H; H-6b), 2.66–2.47 (m, 2H; SCH2CH2CH3),
2.15–1.94 (m, 12H; 4  CH3C]O), 1.69–1.57 (m, 2H;
SCH2CH2CH3), 0.97 (t, J¼ 7.3, 3H; SCH2CH2CH3). 13C NMR (151
MHz, [D1] CDCl3, 25 C, TMS) d¼ 170.56, 169.96, 169.75, 169.72
(4C; C]O), 82.64 (1C; C-1), 71.21, 69.46, 68.91, 66.37 (4C; C-
2,3,4,5) 62.45 (1C; C-6), 33.48 (1C; SCH2CH2CH3), 22.80 (1C;
SCH2CH2CH3), 20.92, 20.70, 20.69, 20.62 (4C; 4  CH3C]O),
13.35 (1C; SCH2CH2CH3), HRMS (ESI-QTOF) m/z calc. for
C17H26O9SNa
+ 429.119 found 429.126.
2-Propynyl-2,3,4,6-tetra-O-acetyl-1-O-a-D-mannopyranoside
(3). A 0.50 M solution of thioglycoside donor 2 (0.250 g,
0.615 mmol, 1.0 equiv.) and propargyl alcohol (0.035 g,
0.615 mmol, 1.0 equiv.) were stirred together in anhydrous
dichloromethane (CH2Cl2) for 0.5 h in a ask lled with Ar
at ambient temperature. A solution of Ph3Bi(OTf)2 (ref. 27)
(0.317 g, 0.430 mmol, 0.700 equiv.) in anhydrous CH2Cl2
was added and the reaction was stirred at ambient
temperature for 4 h (till the consumption of donor was seen
by TLC). The reaction was then quenched by triethylamine,
ltered through a Celite pad, and concentrated under
reduced pressure; the resulting residue was puried by
silica gel column chromatography with hexane–ethyl acetate
(3 : 1) to give a pale white solid 3 (0.188 g, 0.486 mmol,
79%). The 1H NMR, 13C NMR, HRMS matched with data in
the literature.28
1H NMR (600 MHz, [D1] CDCl3, 25 C, TMS) d [5.35 (dd, J ¼
10.0, 3.4 Hz), 5.31 (d, J ¼ 9.8 Hz), 5.29–5.27 (m) (3H; H-2,3,4)],
5.03 (d, J¼ 1.8 Hz, 1H; H-1), 4.31–4.28 (m, 1H, H-6a), 4.28 (d, J¼
2.3 Hz, 2H, CH2CCH), 4.11 (dd, J ¼ 12.3, 2.5 Hz, 1H, H-6b), 4.02
(ddd, J ¼ 9.7, 5.2, 2.4 Hz, 1H, H-5), 2.47 (t, J ¼ 2.4 Hz, 1H,
CH2CCH), 2.17 (s, 3H), 2.11 (s, 3H), 2.04 (s, 3H), 1.99 (s, 3H) (4
CH3C]O).
13C NMR (151MHz, [D1] CDCl3, 25 C, TMS) d 96.23 (1C; C-1),
77.92, 75.62 (2C, CH2CCH), 69.33, 68.97, 68.91, 66.00 (4C; C-
2,3,4,5), 62.30 (1C; C-6), 54.94 (1C; CH2CCH), 20.85, 20.73,
20.68, 20.64 (4C; 4  CH3C]O).
This journal is © The Royal Society of Chemistry 2014 RSC Adv., 2014, 4, 15655–15663 | 15657
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HRMS (ESI-QTOF) m/z calc. for C17H22O10Na
+ 409.110 found
409.111.
2-Propynyl-1-O-a-D-mannose (4). To a solution of 3a (0.188 g,
0.486 mmol) in 10.0 mL anhydrous methanol (MeOH), 0.2 mL
of 0.5 N sodium methoxide (freshly prepared by dissolving
sodium in anhydrous MeOH) was added. The reaction mixture
was stirred at ambient temperature for 1 h, neutralized with
Dowex 50WX8 (H+) cation exchange resin and ltered. The
methanol was removed under reduced pressure and trace
methanol or water was removed by co-evaporation with toluene
(3  5 mL) to give the desired product 4 as pale yellow solid
(0.098 g, 0.447 mmol, 92%), which was directly used in the click
reaction.
General procedure for azide–alkyne Huisgen reaction
To a solution of the pentablock copolymer (1.00 equiv.) and 4
(10 equiv.) in H2O, aqueous solutions of CuSO4$5H2O (0.20
equiv.) and L-ascorbic acid (0.40 equiv.) were sequentially
added. Themixture was stirred at 35 C for 24 h. The solvent was
removed under reduced pressure and residual mixture was
dried under vacuum overnight.
Purication of mannose functionalized pentablock
copolymers/dialysis
The residue aer the click reaction was dissolved in minimum
amount (<3.0 mL) of solvent (33% ethanol in water, except for
PDiPAEM in which case 66% ethanol/water was used). The
solution was then injected into a Slide-A-Lyzer® dialysis cassette
(10 kDa Mw cutoﬀ), and le for stirring overnight for 20 h in
nanopure water. The leover solvent inside the cassette was
then evaporated under reduced pressure and the dialyzed
sample was kept under vacuum overnight for complete dryness.
Phenol sulfuric acid assay
The sugar attached pentablock copolymers were dissolved in
nanopure water at a concentration of 1 mg mL1 and 100 mL
volume per well was added to a 96 well plate. A 150 mL volume of
stock sulfuric acid was added to each well following a 30 mL
volume of 5% phenol. The 96 well plate was heated for 30min at
90 C and the absorbance was read in a microplate reader at the
490 nm wavelength.
Statistical analysis
All error bars represent 95% condence intervals for the mean.
Diﬀerences between groups were analyzed with one-way anal-
ysis of variance (ANOVA) followed by Tukey's multiple
comparison test. The denoted statistical signicance indicates a
p-value #0.05.
Results & discussion
The synthesis & characterization of the family of pentablock
copolymers
A family of pentablock copolymers (PDEAEM, PDMAEM, PDi-
PAEM and PtBAEM) previously developed by our group as
injectable drug delivery devices exhibit remarkable reversible
gelation around physiological temperatures and vary in their
pH-dependent micellization behavior.2,14 These were synthe-
sized using a Pluronic macronitiator triblock and diﬀerent
amine containing cationic blocks utilizing ATRP. To ensure
biocompatibility, the molar mass was maintained below the 20
kDa cut oﬀ for renal excretion by the kidneys.29 Scheme 2 is a
schematic of the ATRP synthesis reaction for the four diﬀerent
pentablock copolymers. The pentablock copolymers were
characterized by 1H NMR and the number average molar mass
(Mn) was calculated from the integral per proton ratio using the
known chain length of the central triblock Pluronic. The 1H
NMR spectra and a table of molecular weights can be found in
Fig. 1 and Table 1 respectively. Previous studies by our research
group with the PDEAEM pentablock copolymer have demon-
strated that these block copolymers form charged spherical
micelles at low pHs with a hydrodynamic radius of approxi-
mately 10 nm that increase in size and transition into cylin-
drical micelles above a critical pH.14,30 These polymers are
potential candidates for injectable gene delivery and as such
were then tested for compatibility as DNA delivery platforms.
DNA condensation & cytotoxicity studies
Agarose gel electrophoresis was used to determine the
minimum concentration of pentablock copolymer required to
form a polyplex based on the ratio of charged nitrogen atoms in
the pentablock copolymer's tertiary amine groups and the
negatively charged phosphate groups in the DNA backbone
denoted as the N/P ratio. Fig. 2 shows uorescent images of
agarose gels containing the four diﬀerent pentablock copoly-
mers at various N/P ratios. In wells where the DNA did not
migrate, the quantity of pentablock copolymer was large
enough to neutralize the negative DNA charge, indicating the
formation of polymer–DNA polyplexes. PDEAEM, PDMAEM and
PtBAEM complexed with DNA at minimumN/P ratios of 3, 1 and
1 respectively. The PDiPAEM pentablock copolymer with the
hydrophobic isopropyl groups was insoluble in water. This
Scheme 2 ATRP synthesis of block copolymer family.
15658 | RSC Adv., 2014, 4, 15655–15663 This journal is © The Royal Society of Chemistry 2014
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pentablock copolymer was unable to complex with DNA at N/P
ratios less than 10, which may be attributed to the necessary
sonication that was required to dissolve this block copolymer. A
lower N/P ratio is desirable when designing a DNA-based
vaccine formulation due to the reduction of the necessary
amounts of the cytotoxic cationic groups on the polymers.
The primary obstacle that researchers developing adjuvants
must overcome is toxicity, since cationic groups that can
complex with DNA can be cytotoxic, which is why the cytotox-
icity of the diﬀerent polymers was investigated.19,31 The cyto-
toxicity of the pentablock copolymers was determined using
a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay. Four pentablock copolymers of similar molecular
weights at the same N/P ratio were tested at low and high
polymer concentration ranges used typically for DNA trans-
fection studies.17,29,32,33 Unfortunately, it was observed that the
cells treated with the PtBAEM pentablock copolymer did not
survive at high or even low concentration ranges. While the
other three polymers showed low cytotoxicity, the diﬀerences
between the PDEAEM, PDMAEM and PDiPAEM pentablock
copolymers were statistically signicant at the higher polymer
concentration range (Fig. 3). The required sonication of the
PDiPAEM pentablock copolymer may have contributed to the
low cytotoxicity of this block copolymer.
Functionalization of pentablock copolymers with D-mannose
via azide–alkyne Huisgen cycloaddition
The D-mannose was attached to the pentablock copolymer via
Huisgen cycloaddition by functionalizing the polymer with an
azide group and the mannose with an alkyne linker. As previ-
ously reported,34 bromo-terminated polyacrylates can be easily
substituted by the nucleophilic azide group, hence the halogen
end groups of the pentablock copolymers were replaced by
azide (Scheme 3). A distinct peak present between 2100 and
2300 cm1 represents the azide functionalization of the penta-
block copolymers (Fig. 4) which was previously absent in the
non-azide functionalized polymers.
We recently developed27 a simple, eﬃcient thioglycoside
activation protocol utilizing bismuth(V) chemistry35,36 with a
wide variety of carbohydrates containing various functional
groups. This method, unlike most other current methods,37,38
can be performed at ambient temperatures without the use of
Fig. 1 1H NMR spectra of pentablock copolymers: (A) PDEAEM (B)
PDMAEM (C) PDiPAEM (D) PtBAEM.
Table 1 Number average molar mass (Mn) and methacrylate chain
length (n) calculated from 1H NMR spectra of pentablock copolymers
Pentablock copolymer Mn g mol
1 n Chain length
PDEAEM 15 500 7.5
PDMAEM 14 300 4.1
PDiPAEM 13 700 2.4
PtBAEM 13 000 0.7
Fig. 2 Agarose gel electrophoresis of pentablock copolymer poly-
plexes at N/P ratios of 1, 3, 5 and 10 with a DNA only control (A)
PDEAEM (B) PDMAEM (C) PDiPAEM (D) PtBAEM. Fig. 3 The diﬀerences in cytotoxicity between the pentablock
copolymers (A) a polymer concentration calculated from an N/P ratio
of 20 for 0.2 mg of DNA per well. (B) A polymer concentration calcu-
lated from an N/P ratio of 20 for 0.6 mg of DNA per well. The data
presented are 95% conﬁdence intervals for the mean for four inde-
pendent experiments and letters indicate statistical diﬀerences
between groups where a p-value #0.05.
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any additives/co-promoters. Moreover, unlike many thioglycoside
activationmethods that rely on promoter interactions with the so
sulfur that preclude the facile use of alkenes anywhere in the
glycosyl donor or acceptor, this bismuth-mediated method was
shown to work eﬀectively in the presence of alkenyl groups. In
order to install the alkyne linker onto the carbohydrate, we further
investigated the application of this method in the presence of
terminal alkynyl systems, which like alkenes are also prone to
addition by-products. The synthesis of the desired mannose
analogue (Scheme 4) containing the alkyne moiety started with
peracetylation of commercially available D-mannose, which was
then converted to a new thiopropylmannoside donor 2. The donor
2 was then activated with Ph3Bi(OTf)2 in presence of propargyl
alcohol to give the alkyne linked mannose 3 in 79% yield, without
any interference with the alkyne moiety. Finally, 3 was deacety-
lated to give the nal alkynyl mannose 4 in overall 50% yield in 5
steps. 1D and 2D NMR spectra of the mannose derivatives are
available in the ESI.†
Aer the azide and alkyne functionalization of the polymer
and mannose respectively, they were coupled together via a
Huisgen azide-alkyne click reaction catalyzed by a mixture of
CuSO4$5H2O and L-ascorbic acid (Scheme 5).
Purication and analysis of the attachment of D-mannose to
pentablock copolymers: IR spectroscopy, and phenol sulfuric
acid assay
The next crucial part was to characterize the attachment as well
as quantify the amount of sugar attached to the polymer.
Unfortunately, the initial studies using mass spectroscopy
(specically MALDI-TOF) and 15N labeled 1-D & 2-D NMR
spectroscopy were not denitive. However, IR spectroscopy
results showed the presence and absence of peaks, particularly
a distinct azide peak (2050–2300 cm1) (Fig. 4) before/aer
reaction, but did not quantify the coupling. The 1HNMR spectra
of the pentablock copolymers before and aer attachment
(ESI†) also shows new peaks in the region of 5–7 ppm, which are
probably from the triazole ring protons and the mannose
protons aer the click reaction. However, since these protons
are too small in number compared to the copolymer protons,
they are diﬃcult to accurately integrate to quantify the
attachment.
In order to accurately quantify the amount of mannose
attached to the polymer, a phenol sulfuric acid assay was carried
out by dissolving the pentablock copolymers in water and
Scheme 3 Azide functionalization of block copolymer family.
Fig. 4 IR spectrum comparison of PDEAEM before azide functional-
ization (top), after azide functionalization (middle) and after azide–
alkyne Huisgen reaction with mannose analogue 4 (bottom).
Scheme 4 Preparation of D-mannose with the alkyne linker.
Scheme 5 Azide–alkyne Huisgen cycloaddition between D-mannose
and the various pentablock copolymers.
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reacting the carbohydrates with phenol in the presence of
sulfuric acid (Fig. 5). Prior to these assays, the mannose func-
tionalized pentablock copolymers were puried from the
unreacted sugar/excess reagents by utilizing dialysis membrane
cassettes to rule out detection of unattached sugar. The sepa-
ration of the excess sugar as well as excellent coupling of the two
were clearly evident in the phenol sulfuric acid assay values
from before and aer dialysis samples. The PDiPAEM penta-
block copolymer was slightly soluble in water with vortexing but
continuously precipitated out of solution at relatively low
concentrations. For this reason, sonication was used for the
mannose functionalized PDiPAEM pentablock copolymer for all
characterization assays. Overall, it was determined that the
dialyzed pentablock copolymers had approximately two moles
of mannose present per mole polymer indicating that the azide–
alkyne click reaction produced near-complete conversion.
DNA condensation of mannose functionalized block
copolymers
We envisioned that the addition of the mannose to the penta-
block copolymers should not hamper their ability to condense
DNA since this ability comes from the tertiary amine groups
present in the outerblocks. Nevertheless, we performed gel
electrophoresis on the mannose attached copolymers to test
this hypothesis. TheminimumN/P ratios for DNA complexation
did not change for any of the four pentablock copolymers aer
the azide–alkyne Huisgen reaction indicating that the attached
mannose did not impact the capability of the block copolymers
to condense DNA (Fig. 6).
Further discussion
Based on all the above studies, the PDEAEM and PDMAEM
pentablock copolymers appear to be the optimal subunit
vaccine candidates due to their low cytotoxicity and relatively
small N/P ratios required for DNA condensation. The PDiPAEM
pentablock copolymer was insoluble in water, requiring the use
of slightly cytotoxic DMSO solvent or use of sonication, and did
not complex with the DNA plasmid at relatively low N/P ratios.
Although the PtBAEM pentablock copolymer complexed with
DNA at a low N/P ratios, it proved to be highly cytotoxic.
C-type lectin receptors expressed by dendritic cells and
macrophages internalize pathogens aer binding carbohydrate
structures on their surface.39 Recently, a carbohydrate-func-
tionalized polymer synthesized by Charville et al. demonstrated
that copolymers containing a higher degree of mannose func-
tionalization were more prone to binding lectin receptors.40 Our
method which includes the functionalization with mannose
alkyne linker synthesized by bismuth(V)-mediated activation of
a thioglycoside has yielded pentablock copolymers with
hydrophobic polyoxyproplyene blocks that self-assemble into
micelles. These pentablock copolymers are capable of
condensing DNA for gene delivery through tertiary amine
groups in the outer blocks.
Carbohydrate functionalized particles have been shown to
enhance the expression of MHC II, costimulatory molecules and
C-type lectin receptors by dendritic cells.20 The high carbohy-
drate-functionalization of the pentablock copolymers may
provide benets when compared to other reported functional-
ized vaccine platforms, which typically focus on the decoration
of particle surfaces.41–48 The continued presence of sugars
attached to polymer may provide increased and longer-lasting
activation of immune cells as compared to a sugar-decorated
particle, which may erode and slough oﬀ the sugars quickly.
Conclusions
Herein we report the synthesis of a family of pentablock
copolymers based on Pluronic macrointiators. These four
polymers were then tested as potential DNA vaccine candidates
using cytotoxicity assays and their DNA complexation abilities.
The block copolymers PDEAEM and PDMAEM were chosen as
the lead candidates for a DNA vaccine delivery platform due to
their ability to condense DNA at low N/P ratios and with rela-
tively low cytotoxicity. All four of the block copolymers were
successfully functionalized with mannose by a high-yielding
azide–alkyne Huisgen reaction. In addition, the cheap, non-
toxic Bi(V)-mediated thioglycoside activation method proved to
be applicable to cases containing alkynes for the synthesis of
alkynyl mannose in high yield. The addition of mannose to the
polymer did not destroy the ability of the polymers to complex
Fig. 5 Quantiﬁcation of mannose functionalized pentablock copoly-
mers. The data presented are 95% conﬁdence intervals for the mean
for four independent experiments.
Fig. 6 Agarose gel electrophoresis of mannose functionalized pen-
tablock copolymer polyplexes at N/P ratios of 1, 3, 5 and 10 with a DNA
only control (A) PDEAEM (B) PDMAEM (C) PDiPAEM (D) PtBAEM.
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DNA and therefore these new sugar-modied materials have the
potential to activate APCs. These promising virus-mimicking
nanoparticles for DNA-based vaccine delivery will be evaluated
in future studies for APC activation and immune response
generation.
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